Strategies to apply 3Rs in preclinical testing

التفاصيل البيبلوغرافية
العنوان: Strategies to apply 3Rs in preclinical testing
المؤلفون: Angeles Rodriguez Basso, Susana Gorzalczany
المصدر: Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, Vol 9, Iss 5, Pp n/a-n/a (2021)
سنة النشر: 2020
مصطلحات موضوعية: non clinical, Animal Use Alternatives, Biomedical Research, Computer science, media_common.quotation_subject, Drug Evaluation, Preclinical, reduction, RM1-950, In Vitro Techniques, replacement, Drug Development, Animals, Invited Reviews, refinement, Quality (business), Computer Simulation, General Pharmacology, Toxicology and Pharmaceutics, Animal testing, Drug Approval, media_common, Research Highlights from South America, Alternative methods, Invited Review, South America, testing approaches, Editorial, Neurology, Risk analysis (engineering), Preclinical testing, Non clinical, Therapeutics. Pharmacology
الوصف: Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in response to the necessity to reduce the number of animals used in experimentation, to guarantee their welfare; resorting to animal models only when strictly necessary. The three Rs (Replacement, Reduction, and Refinement), seek to ensure the rational and respectful use of laboratory animals and maintain an adequate projection in terms of bioethical considerations. This article describes different approaches to apply 3Rs in preclinical experimentation for either research or regulatory purposes.
3 Rs testing approaches.
تدمد: 2052-1707
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7837ed4f0ef7cc6fb26b3c1549a8a5a5Test
https://pubmed.ncbi.nlm.nih.gov/34609071Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....7837ed4f0ef7cc6fb26b3c1549a8a5a5
قاعدة البيانات: OpenAIRE